Atlas Trials

A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 50 to 70 Years

Clinical trial NCT06335849 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06335849
Sponsor
Guangzhou Patronus Biotech Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2024-03-27
Primary completion
2025-09-30
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.